Express News | Capricor Therapeutics Inc - Plans to Complete Bla Submission by End of 2024
Capricor Therapeutics Announces Initiation of Rolling Submission of Biologics License Application (BLA) With U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
Express News | Capricor Therapeutics Announces Initiation of Rolling Submission of Biologics License Application (Bla) With U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
PepsiCo, DocuSign, Robinhood And Other Big Stocks Moving Higher On Tuesday
Oppenheimer Maintains Capricor Therapeutics(CAPR.US) With Buy Rating, Maintains Target Price $43
Oppenheimer Keeps Their Buy Rating on Capricor Therapeutics (CAPR)
Sector Update: Health Care Stocks Steady Late Afternoon
Sector Update: Health Care
Catalyst Watch: Tesla's Robotaxi Reveal, AI Events for Nvidia, AMD, and HP Enterprise
Capricor Stock Rallies 20% on DMD Data Presentation Update
Apogee Enterprises Posts Upbeat Earnings, Joins Frontier Group, JetBlue Airways And Other Big Stocks Moving Higher On Friday
Capricor Therapeutics To Present Long-Term Data From HOPE-2 Open Label Extension Study At 2024 World Muscle Society Congress October 8-12, 2024
Is Capricor Therapeutics, Inc. (CAPR) the Best Russell 2000 Stock to Buy According to Analysts?
Capricor Therapeutics Call Volume Above Normal and Directionally Bullish
IGM Biosciences, CPI Card And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Here's How Much $100 Invested In Capricor Therapeutics 5 Years Ago Would Be Worth Today
Crude Oil Down Over 1%; Stitch Fix Shares Plummet
Capricor's FDA Plan for Deramiocel Lures Institutional Investors -- Market Talk
12 Health Care Stocks Moving In Wednesday's Intraday Session
Hewlett Packard Enterprise, Nvidia, Progress Software And Other Big Stocks Moving Higher On Wednesday